Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
TORONTO, (GLOBE NEWSWIRE) — Avicanna Inc. (āAvicannaā or the āCompany) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the […]
